BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 12495906)

  • 1. Dysregulated expression of Bcl-xL in CD34+ cells isolated from patients with refractory anemia with excess of blasts during megakaryocytic differentiation.
    Martini M; Luongo M; Teofili L; Di Mario A; Leone G; Larocca LM
    Haematologica; 2002 Dec; 87(12):1342-3. PubMed ID: 12495906
    [No Abstract]   [Full Text] [Related]  

  • 2. Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia.
    Zhang L; Zhao H; Sun A; Lu S; Liu B; Tang F; Feng Y; Zhao L; Yang R; Han ZC
    Haematologica; 2004 Oct; 89(10):1199-206. PubMed ID: 15477204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Timing and expression level of protein kinase C epsilon regulate the megakaryocytic differentiation of human CD34 cells.
    Gobbi G; Mirandola P; Sponzilli I; Micheloni C; Malinverno C; Cocco L; Vitale M
    Stem Cells; 2007 Sep; 25(9):2322-9. PubMed ID: 17569788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
    Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
    Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene Ontology-driven transcriptional analysis of CD34+ cell-initiated megakaryocytic cultures identifies new transcriptional regulators of megakaryopoiesis.
    Fuhrken PG; Chen C; Apostolidis PA; Wang M; Miller WM; Papoutsakis ET
    Physiol Genomics; 2008 Apr; 33(2):159-69. PubMed ID: 18252802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between survivin mRNA expression and homoharringtonine induced apoptosis of malignant hematopoietic cells.
    Cai Z; Bao HY; Lin MF
    Chin Med J (Engl); 2005 Apr; 118(7):548-54. PubMed ID: 15820085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD226 is expressed on the megakaryocytic lineage from hematopoietic stem cells/progenitor cells and involved in its polyploidization.
    Ma D; Sun Y; Lin D; Wang H; Dai B; Zhang X; Ouyang W; Jian J; Jia W; Xu X; Jin B
    Eur J Haematol; 2005 Mar; 74(3):228-40. PubMed ID: 15693793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro dual effect of arsenic trioxide on hemopoiesis: inhibition of erythropoiesis and stimulation of megakaryocytic maturation.
    Saulle E; Riccioni R; Pelosi E; Stafness M; Mariani G; De Tuglie G; Peschle C; Testa U
    Blood Cells Mol Dis; 2006; 36(1):59-76. PubMed ID: 16360329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Emperipolesis by megakaryocytes in RAEB in T (refractory anemia with excess of blasts in transformation)].
    Natori H; Natori K; Naito K; Nakamura E; Tanaka K; Egami K; Honda J; Imamura Y; Osabe S; Yasuda K
    Rinsho Ketsueki; 1988 Sep; 29(9):1504-10. PubMed ID: 3216522
    [No Abstract]   [Full Text] [Related]  

  • 11. [The BCL-xL and ACR-1 genes promote differentiation and reduce apoptosis in muscle fibers of mdx mice].
    Mikhaĭlov VM; Kropotov AV; Zelenin AV; Krutilina RI; Kolesnikov VA; Zelenina IA; Baranov AN; Shteĭn GI; Ostapenko OV; Tomilin NV; Baranov VS
    Genetika; 2002 Nov; 38(11):1445-50. PubMed ID: 12500669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H; Sen S; Mathur M; Bahadur S; Singh N
    Head Neck; 2004 Aug; 26(8):733-40. PubMed ID: 15287041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zyxin is up-regulated during megakaryocytic differentiation of human UT-7/c-mpl cells.
    Decraene C; Garçon L; Lacout C; Sabri S; Auffray C; Vainchenker W; Duménil D; Piétu G; Svinartchuk F
    Biochem Biophys Res Commun; 2004 May; 318(2):439-43. PubMed ID: 15120620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA interference by expression of short hairpin RNAs suppresses bcl-xL gene expression in nasopharyngeal carcinoma cells.
    Liu F; He CW; Zhang YF; Zhou KY
    Acta Pharmacol Sin; 2005 Feb; 26(2):228-34. PubMed ID: 15663904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
    Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
    Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bcl-xL and bcl-2 proteins in melanoma progression and UVB-induced apoptosis.
    Zhang H; Rosdahl I
    Int J Oncol; 2006 Mar; 28(3):661-6. PubMed ID: 16465371
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atypical antipsychotics attenuate neurotoxicity of beta-amyloid(25-35) by modulating Bax and Bcl-X(l/s) expression and localization.
    Wei Z; Mousseau DD; Richardson JS; Dyck LE; Li XM
    J Neurosci Res; 2003 Dec; 74(6):942-7. PubMed ID: 14648600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 or bcl-XL gene therapy increases neural plasticity proteins nestin and c-fos expression in PC12 cells.
    Gal A; Pentelenyi K; Remenyi V; Wappler EA; Safrany G; Skopal J; Nagy Z
    Neurochem Int; 2009 Sep; 55(5):349-53. PubMed ID: 19375463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Ets-1 in human hematopoietic progenitor cells blocks erythroid and promotes megakaryocytic differentiation.
    Lulli V; Romania P; Morsilli O; Gabbianelli M; Pagliuca A; Mazzeo S; Testa U; Peschle C; Marziali G
    Cell Death Differ; 2006 Jul; 13(7):1064-74. PubMed ID: 16294212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
    Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
    Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.